This presents a critical risk for patient safety that reputable manufacturers will need to address by working closely with regulators to ensure the security of the supply chain and robust quality control
[23] [24] The FDA emphasizes that healthcare providers should follow standard clinical practice when prescribing these medications, including thorough patient assessment and ongoing monitoring
"GLP-1s have the best chance of helping people achieve and sustain lasting weight reduction when they are paired with strong nutrition guidance and lifestyle support," said Callahan
This trend is especially significant in price-sensitive or developing nations due to the expensive nature of branded treatments
Tesofensine, a triple monoamine reuptake inhibitor, works primarily in the brain to decrease appetite and potentially increase energy expenditure
According to the brand's weight-loss page, semaglutide is available as a once-weekly injection